MARINUS PHARMACEUTICALS, INC. Quarterly Operating Margin in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q2 2024.
  • Marinus Pharmaceuticals, Inc. Operating Margin for the quarter ending June 30, 2024 was -447 %, a 6.29% increase year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Operating Margin for 2023 was -424 %, a 4.15% increase from 2022.
  • Marinus Pharmaceuticals, Inc. annual Operating Margin for 2022 was -443 %, a 29.9% increase from 2021.
  • Marinus Pharmaceuticals, Inc. annual Operating Margin for 2021 was -632 %, a 84% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -447 +30 +6.29% Apr 1, 2024 Jun 30, 2024
Q1 2024 -475 +121 +20.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -424 +18.4 +4.15% Oct 1, 2023 Dec 31, 2023
Q3 2023 -405 +153 +27.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -477 -115 -31.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -595 -284 -90.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -443 +189 +29.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -558 Jul 1, 2022 Sep 30, 2022
Q2 2022 -361 Apr 1, 2022 Jun 30, 2022
Q1 2022 -312 Jan 1, 2022 Mar 31, 2022
Q4 2021 -632 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.